Blockade of Vascular Endothelial Cell Growth Factor Receptor Signaling Is Sufficient to Completely Prevent Retinal Neovascularization

This publication has 24 references indexed in Scilit:

• PTK787/ZK 222584, a novel and potent inhibitor of vascular endothelial growth factor receptor tyrosine kinases, impairs vascular endothelial growth factor-induced responses and tumor growth after oral administration.
  2000
• Dramatic Inhibition of Retinal and Choroidal Neovascularization by Oral Administration of a Kinase Inhibitor
  The American Journal of Pathology, 1999
• Evolution of neovascularization in mice with overexpression of vascular endothelial growth factor in photoreceptors.
  1998
• Inhibition of platelet‐derived growth factor receptor tyrosine kinase inhibits vascular smooth muscle cell migration and proliferation
  The FASEB Journal, 1997
• Transgenic mice with increased expression of vascular endothelial growth factor in the retina: a new model of intraretinal and subretinal neovascularization.
  1997
• Essential Role of Growth Hormone in Ischemia-Induced Retinal Neovascularization
  Science, 1997
• Antagonists of integrin alpha v beta 3 inhibit retinal neovascularization in a murine model.
  1996
• Oligodeoxynucleotides inhibit retinal neovascularization in a murine model of proliferative retinopathy.
  Proceedings of the National Academy of Sciences, 1996
• Subcutaneous injection of a cyclic peptide antagonist of vitronectin receptor–type integrins inhibits retinal neovascularization
  Nature Medicine, 1996
• Inhibition of Vascular Endothelial Growth Factor Prevents Retinal Ischemia—Associated Iris Neovascularization in a Nonhuman Primate
  Archives of Ophthalmology (1950), 1996